Sage Therapeutics Inc
XNAS: SAGE
Sage Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting ...
Read More
8.70
-0.08
(-0.91%)
7.4M
XNAS Volume
High volume today
XNAS 29 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Sage Therapeutics Inc is on 31 Jul 2025 for the purpose of Sage Therapeutics Inc Second Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Sage Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..